Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

QR Code

Oligonucleotide Applications for the Therapy and Diagnosis of Human Papillomavirus Infection

None

Saved in:

Bibliographic Details
Main Authors:	Benítez-Hess, María L., Toscano-Garibay, Julia D., Alvarez-Salas, Luis M.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26629
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular Diagnosis of Human Papillomavirus
by: Dutra, I., et al.
Published: (2012)

Epidemiology of Mucosal Human Papillomavirus (HPV) Infections Among Adult and Children
by: Trottier, Helen
Published: (2012)

Human Papillomavirus Infection in Croatian Men: Prevalence and HPV Type Distribution
by: Grahovac, Blaženka, et al.
Published: (2012)

A Multi-Targeted Antisense Oligonucleotide-Based Therapy Directed at Phosphodiesterases 4 and 7 for COPD
by: Seguin, Rosanne, et al.
Published: (2012)

Human Papillomavirus Type Distribution in Southern China and Taiwan
by: Chen, Chung-Yung, et al.
Published: (2012)

The Interaction between Human Papillomavirus Proteins and Cytoskeletal Filaments
by: Oz, Zehra Safi
Published: (2012)

Idiopathic male infertility and human papillomavirus infection
by: Kh. S. Ibishev, et al.
Published: (2019-07-01)

Current state of the problem of human papillomavirus infection
by: L. A. Yusupovа, et al.
Published: (2021-06-01)

FEATURES OF PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN
by: KRISTINA V. Marochko, et al.
Published: (2017-09-01)

Human Telomerase Reverse Transcriptase Gene Antisense Oligonucleotide Increases the Sensitivity of Pancreatic Cancer Cells to Gemcitabine In Vitro
by: Liu, Yong-ping, et al.
Published: (2012)

Human Papillomavirus Worldwide Distribution in Women Without Cervical Cancer
by: Dutra, I., et al.
Published: (2012)

Molecular Bases of Human Papillomavirus Pathogenesis in the Development of Cervical Cancer
by: Pedroza-Saavedra, Adolfo, et al.
Published: (2012)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Antiviral activity of modified oligonucleotides in human lymphoid cells infected with a strain of HIV‐1
by: L. G. Gotfrid, et al.
Published: (2025-01-01)

The effect of vaginal probiotic therapy on the outcome of papillomavirus infection
by: V. V. Oleynik, et al.
Published: (2022-01-01)

The role of herpes and human papillomavirus infection in prostate and bladder carcinogenesis
by: L. M. Mikhaleva, et al.
Published: (2022-01-01)

Human papillomavirus infection and fertility alteration: a systematic review.
by: Tiatou Souho, et al.
Published: (2015-01-01)

Oxidative stress and antioxidant modulation in cervical infection by the human papillomavirus
by: Tatiana Mugnol Schöffel, et al.
Published: (2025-07-01)

Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01)

Role of Chronic Inflammation and Resulting DNA Damage in Cervical Carcinogenesis Induced by Human Papillomavirus
by: Hiraku, Yusuke
Published: (2012)

Achievements and Prospects of Vaccination against Human Papillomavirus Infection and Associated Diseases
by: G. N. Minkina
Published: (2020-05-01)

Epidemiology and Diagnosis of Human Respiratory Syncytial Virus Infections
by: Akhter, Javed, et al.
Published: (2011)

Programmable Single-Stranded Circular Antisense Oligonucleotides for Multitarget Gene Therapy
by: Yufan Pan, et al.
Published: (2025-07-01)

VACCINATION AGAINST HUMAN PAPILLOMAVIRUS INFECTION: A SAFE SOLUTION TO THE GLOBAL PROBLEM
by: M.G. Galitskaya, et al.
Published: (2011-08-01)

MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION
by: O. S. Alyautdina, et al.
Published: (2018-09-01)

Vaccination against human papillomavirus after adjuvant therapy of cervical intraepithelial neoplasia
by: I. I. Kutsenko, et al.
Published: (2022-06-01)

The situation with vaccination in Shkodra region after the first year of implementation of human papillomavirus vaccine
by: Zamira Shabani, et al.
Published: (2025-06-01)

Functionalized oligonucleotides, synthetic catalysts as enzyme mimics
by: Chardet, Crystalle, et al.
Published: (2024-04-01)

Aptamer-mediated delivery of therapeutic oligonucleotides in glioblastoma
by: Giorgia Castellani, et al.
Published: (2025-10-01)

Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection
by: Song Qing, et al.
Published: (2017-04-01)

Features of human papillomavirus infection frequency in different regions of the Russian Federation (literature review)
by: E. V. Belyaeva, et al.
Published: (2018-05-01)

Why Should You Care About Oral Gonorrhea and Oral Human Papillomavirus Infection?
by: Jae Yong Jeong, et al.
Published: (2023-04-01)

Human papillomavirus infection in males: implications for fertility, assisted reproductive outcomes, and vaccination strategies
by: Xian-hua Sun, et al.
Published: (2025-06-01)

VACCINE AGAINST PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER
by: M.G. Galitskaya, et al.
Published: (2008-09-01)

Overview of the Global Vaccination against Human Papillomavirus
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01)

Genetic and epigenetic mechanisms of regulation of human papillomavirus
by: S. V. Vinokurova
Published: (2016-06-01)

THE ROLE OF HUMAN PAPILLOMAVIRUS IN DEVELOPMENT OF OROPHARYNGEAL CANCER
by: A. I. Stukan, et al.
Published: (2016-10-01)

The necessity and challenges of human papillomavirus testing for men
by: Wenbo Ren, et al.
Published: (2025-06-01)

A dual fluorescence-based reporter assay for real-time determination of siRNA- and antisense oligonucleotide-mediated knockdown
by: Felix Heß, et al.
Published: (2025-09-01)

Phosphate-modified CpG oligonucleotides induce in vitro maturation of human myeloid dendritic cells
by: A. A. Ostanin, et al.
Published: (2020-10-01)